About Agennix

• Overview
• Management Board
• Supervisory Board
• Locations

Development Programs

• Oral Talactoferrin
  • Non-small cell lung cancer
  • Phase III Clinical Trials
  • Severe Sepsis
• Other Development Programs
  • Topical Talactoferrin
  • RGB-286638
  • Satraplatin

Investor Relations

• Stock
• Key Figures
• Financial Reports
  • 2010
  • 2009
• Directors Dealings
• Corporate Governance
  • Compliance Declaration
  • Management and Control Structures
  • Compensation of the Boards
  • Shareholdings of the Board
• Annual Shareholders' Meeting
• Yearly Document
• Webcasts
• Press Releases
  • 2010
  • 2009
• Ad Hoc Announcements
  • 2011
  • 2010
  • 2009
• Information Requests
• Calendar
• Contact

News and media

• Press Releases
  • 2010
  • 2009
• Ad Hoc Announcements
  • 2010
  • 2009
• Contact

Careers

• Germany
• USA